Breast screening: using MRI with higher risk women
Technical guidelines for healthcare professionals screening women at a higher risk of developing breast cancer.
Applies to England
Documents
Details
Healthcare professionals working in NHS breast screening programme should use these guidelines.
»Ê¹ÚÌåÓýappy apply to the use of magnetic resonance imaging (MRI) equipment when screening higher risk women and include:
- standards for equipment and image acquisition
- reporting MRI examinations
- quality control and quality assurance
This publication was previously published by Public Health England, which closed on 30 September 2021.
Updates to this page
-
Added clarification that publication was previously published by Public Health England.
-
»Ê¹ÚÌåÓýapp Information has been updated and reformatted into HTML. This guidance has been revised specifically in the following areas: â€� there are more details on the image acquisition parameters in the new guidance in section 2.5. â€� there are more details on the viewing tools such as colour parametric software in section 2.6. â€� all women should have second-look ultrasound at assessment rather than a selected group (section 3.4) â€� short term recall should be undertaken between 3 and 6 months instead of between 6 and 12 months (section 3.6). â€� the updated report gives more details on undertaking QC using breast coil element check and Suppression effectiveness (section 4.1) â€� there are changes to the equipment standards stated in Appendix 2 â€� standards set out in Appendix 2 of 2012 report on standards for readers and centres have been removed. â€� the MRI accreditation form has been removed from the updated report.
-
First published.